QuellTX Logo

About Us

About Quell

At Quell we seek to deliver truly innovative, life-changing therapies for our patients. Our vision as a company is to build a major global biopharmaceutical company bringing transformational and valued therapies for a range of autoimmune and inflammatory diseases, as well as preventing rejection in organ transplantation, based on modular engineered Tregs.

Our Company

Quell was founded in March 2019 in partnership with six prominent immunological experts from King’s College London, University College London and Hannover Medical School, and is led by Iain McGill, a leading pharmaceutical executive with extensive relevant experience, having spent the majority of his 25 years in the industry in immunology, including the areas of solid organ and cell transplantation. The Company was founded with initial series A financing, led by Syncona Ltd who committed £34M with a further £1M contributed by UCL Technology Fund.

Our Vision

Transformative Valued Therapies

Quell is focused on delivering therapies which are valued by physicians, patients and payors, which have the promise of delivering transformational results for our patients.

Keeping the Patient Central in all our Efforts

At Quell we keep the patient at the forefront of our minds. Always.

Build a Strong Culture

Culture drives decision making and actions in an organisation. Quell is building a unique and engaging culture which enables us to achieve our goals and live our values.

Our Leadership Team

The partnership between the experienced Quell leadership team and our six founding experts, gives Quell an unparalleled leadership opportunity in the exciting field of therapeutic Tregs.

Iain McGill

Iain McGill

Chief Executive Officer

Luke Henry

Luke Henry

Vice President Operations & Corporate Development

Bernd Schmidt

Bernd Schmidt

Vice President Product Delivery

Dr Marc Martinez-Llordella

Dr Marc Martinez-Llordella

Founder and Vice President Biology

Mark Fox

Mark Fox

Director of Finance

Jodie Albutt

Jodie Albutt

Head of Intellectual Property

Our Founders


Our Board of Directors